Alcon Inc.'s acquisition of LENSAR, Inc. remains pending, with an FTC antitrust review likely delaying the closing. Learn ...

A fourth delay hits Staar Surgical’s shareholder vote on Alcon's $1.6B takeover as Broadwood Partners calls the deal flawed ...

STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer® Lens (ICL) today announced that Alcon (SIX/NYSE: ALC) has exercised its right under the Alcon merger agreement to ...

Swiss eyecare giant Alcon has made a new offer for Staar Surgical worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal despite opposition from Staar's biggest shareholder.

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following open letter to ...

Please provide your email address to receive an email when new articles are posted on . Alcon will buy Lensar’s outstanding shares for $14 per share. The deal is expected to close in the second half ...

Alcon, an international eye care company with facilities in Berks County, has announced it plans to acquire STAAR Surgical Co. Under the terms of the agreement announced Tuesday, Alcon will purchase ...

Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...

Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its Fort Worth campus. Alcon, which started in Fort Worth and has grown to ...

Eye care device company Alcon will lay off as many as 75 third-party food service workers at its Fort Worth campus on Christmas Eve, according to a company memo sent to the workers. The employees work ...